Literature DB >> 27471270

MicroRNA-33 Regulates the Innate Immune Response via ATP Binding Cassette Transporter-mediated Remodeling of Membrane Microdomains.

Lihua Lai1, Kathleen M Azzam1, Wan-Chi Lin1, Prashant Rai1, Julie M Lowe1, Kristin A Gabor1, Jennifer H Madenspacher1, Jim J Aloor1, John S Parks2, Anders M Näär3, Michael B Fessler4.   

Abstract

MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by promoting degradation and/or repressing translation of specific target mRNAs. Several miRNAs have been identified that regulate the amplitude of the innate immune response by directly targeting Toll-like receptor (TLR) pathway members and/or cytokines. miR-33a and miR-33b (the latter present in primates but absent in rodents and lower species) are located in introns of the sterol regulatory element-binding protein (SREBP)-encoding genes and control cholesterol/lipid homeostasis in concert with their host gene products. These miRNAs regulate macrophage cholesterol by targeting the lipid efflux transporters ATP binding cassette (ABC)A1 and ABCG1. We and others have previously reported that Abca1(-/-) and Abcg1(-/-) macrophages have increased TLR proinflammatory responses due to augmented lipid raft cholesterol. Given this, we hypothesized that miR-33 would augment TLR signaling in macrophages via a raft cholesterol-dependent mechanism. Herein, we report that multiple TLR ligands down-regulate miR-33 in murine macrophages. In the case of lipopolysaccharide, this is a delayed, Toll/interleukin-1 receptor (TIR) domain-containing adapter-inducing interferon-β-dependent response that also down-regulates Srebf-2, the host gene for miR-33. miR-33 augments macrophage lipid rafts and enhances proinflammatory cytokine induction and NF-κB activation by LPS. This occurs through an ABCA1- and ABCG1-dependent mechanism and is reversible by interventions upon raft cholesterol and by ABC transporter-inducing liver X receptor agonists. Taken together, these findings extend the purview of miR-33, identifying it as an indirect regulator of innate immunity that mediates bidirectional cross-talk between lipid homeostasis and inflammation.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ABC transporter; cholesterol; lipid raft; macrophage; microRNA (miRNA); toll-like receptor (TLR)

Mesh:

Substances:

Year:  2016        PMID: 27471270      PMCID: PMC5016698          DOI: 10.1074/jbc.M116.723056

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Crosstalk between reverse cholesterol transport and innate immunity.

Authors:  Kathleen M Azzam; Michael B Fessler
Journal:  Trends Endocrinol Metab       Date:  2012-03-10       Impact factor: 12.015

2.  MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages.

Authors:  Ri-sheng Huang; Guan-qiong Hu; Bin Lin; Zhi-yi Lin; Cheng-chao Sun
Journal:  J Investig Med       Date:  2010-12       Impact factor: 2.895

3.  Lipopolysaccharide represses the expression of ATP-binding cassette transporter G1 and scavenger receptor class B, type I in murine macrophages.

Authors:  Youngki Park; Tho X Pham; Jiyoung Lee
Journal:  Inflamm Res       Date:  2012-01-13       Impact factor: 4.575

4.  ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation.

Authors:  Loretta Ma; Fumin Dong; Maryam Zaid; Ashok Kumar; Xiaohui Zha
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

5.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

6.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

7.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

8.  Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation.

Authors:  Kathleen A Smoak; Jim J Aloor; Jennifer Madenspacher; B Alex Merrick; Jennifer B Collins; Xuewei Zhu; Giorgio Cavigiolio; Michael N Oda; John S Parks; Michael B Fessler
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

9.  miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Young-Jun Park; Yuko Tsuruta; Edward Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

10.  Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.

Authors:  Kathleen Smoak; Jennifer Madenspacher; Samithamby Jeyaseelan; Belinda Williams; Darlene Dixon; Katie R Poch; Jerry A Nick; G Scott Worthen; Michael B Fessler
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

View more
  23 in total

1.  Epithelial membrane protein 2 governs transepithelial migration of neutrophils into the airspace.

Authors:  Wan-Chi Lin; Kymberly M Gowdy; Jennifer H Madenspacher; Rachel L Zemans; Kazuko Yamamoto; Miranda Lyons-Cohen; Hideki Nakano; Kyathanahalli Janardhan; Carmen J Williams; Donald N Cook; Joseph P Mizgerd; Michael B Fessler
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 2.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

3.  Cholesterol 25-hydroxylase promotes efferocytosis and resolution of lung inflammation.

Authors:  Jennifer H Madenspacher; Eric D Morrell; Kymberly M Gowdy; Jeffrey G McDonald; Bonne M Thompson; Ginger Muse; Jennifer Martinez; Seddon Thomas; Carmen Mikacenic; Jerry A Nick; Edward Abraham; Stavros Garantziotis; Renee D Stapleton; Julie M Meacham; Mary Jane Thomassen; William J Janssen; Donald N Cook; Mark M Wurfel; Michael B Fessler
Journal:  JCI Insight       Date:  2020-06-04

Review 4.  MicroRNAs and lipid metabolism.

Authors:  Binod Aryal; Abhishek K Singh; Noemi Rotllan; Nathan Price; Carlos Fernández-Hernando
Journal:  Curr Opin Lipidol       Date:  2017-06       Impact factor: 4.776

Review 5.  Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk.

Authors:  Tessa J Barrett; Andrew J Murphy; Ira J Goldberg; Edward A Fisher
Journal:  Ann N Y Acad Sci       Date:  2017-08       Impact factor: 5.691

Review 6.  Immunometabolic Signaling Pathways Contribute to Macrophage and Dendritic Cell Function.

Authors:  Lucas T Jennelle; Aditya P Dandekar; Tshifhiwa Magoro; Young S Hahn
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

7.  Conditional Deoxyribozyme-Nanoparticle Conjugates for miRNA-Triggered Gene Regulation.

Authors:  Jiahui Zhang; Rong Ma; Aaron Blanchard; Jessica Petree; Hanjoong Jo; Khalid Salaita
Journal:  ACS Appl Mater Interfaces       Date:  2020-08-17       Impact factor: 9.229

Review 8.  Lipid rafts as a therapeutic target.

Authors:  Dmitri Sviridov; Nigora Mukhamedova; Yury I Miller
Journal:  J Lipid Res       Date:  2020-03-23       Impact factor: 5.922

9.  Crohn's disease IRGM risk alleles are associated with altered gene expression in human tissues.

Authors:  Teminioluwa A Ajayi; Cynthia L Innes; Sara A Grimm; Prashant Rai; Ryan Finethy; Jörn Coers; Xuting Wang; Douglas A Bell; John A McGrath; Shepherd H Schurman; Michael B Fessler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-18       Impact factor: 4.052

10.  Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis.

Authors:  Nathan L Price; Noemi Rotllan; Alberto Canfrán-Duque; Xinbo Zhang; Paramita Pati; Noemi Arias; Jack Moen; Manuel Mayr; David A Ford; Ángel Baldán; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.